Erythrocyte Sedimentation Rate/viscosity Patents (Class 600/370)
  • Patent number: 11747257
    Abstract: An apparatus for particle characterisation, comprising: a sample cell for holding a sample; a light source configured to illuminate the sample with an illuminating beam and a plurality of light detectors, each light detector configured to receive scattered light resulting from the interaction between the illuminating beam and the sample along a respective detector path, wherein each respective detector path is at substantially the same angle to the illuminating beam.
    Type: Grant
    Filed: June 23, 2021
    Date of Patent: September 5, 2023
    Assignee: Malvern Panalytical Limited
    Inventor: Jason Corbett
  • Patent number: 11426498
    Abstract: Apparatuses and methods of using them to collect blood, are provided, by first ensuring that the patient's skin is properly cleaned, to prevent contamination of the collected blood. One feature is a blood collection device configured to collect blood from a patient. Another feature is a scrub timer integrated into the device and configured to indicate to a user a scrub time period prior to beginning a blood draw process. The scrub timer can be configured to audibly and/or visually indicate to a user the start and stop times of a scrub cleaning process. In one embodiment, the scrub timer can be restarted, either manually or automatically, if the scrub cleaning process is not followed properly.
    Type: Grant
    Filed: June 1, 2015
    Date of Patent: August 30, 2022
    Assignee: Applied Science, Inc.
    Inventors: James A. Bancroft, James E. Goodnow, II
  • Patent number: 10314502
    Abstract: Systems and methods for evaluating multiple candidate sensing vectors for use in sensing electrical activity of a heart are disclosed. The system can sense physiologic signals using each of a plurality of candidate sensing vectors, and generate respective signal intensity indicators and interference indicators using the physiologic signals sensed by using the respective sensing vectors. The system can also receive electrode information of each of the candidate sensing vectors, including information about sensing electrodes that are also used for delivering cardiac electrostimulation. The system can rank at least some of the plurality of candidate sensing vectors according to the signal intensity indicators, the interference indicators, and the electrode information. The system can also include a user interface for displaying the ranked sensing vectors, and allowing the user to select at least one sensing vector for use in sensing the cardiac electrical activity.
    Type: Grant
    Filed: May 25, 2016
    Date of Patent: June 11, 2019
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Les N. Peterson, Sunipa Saha, Adam MacEwen
  • Patent number: 8480581
    Abstract: Methods and systems for implantably determining a patient's anemia status and treating anemia are described. Blood viscosity is compared one or more thresholds to determine a patient's anemia status. Therapy, in the form of electrical stimulation therapy or administration of a pharmaceutical delivered to the patient's kidneys or hypothalamus is controlled based on the anemia status.
    Type: Grant
    Filed: March 23, 2010
    Date of Patent: July 9, 2013
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Yunlong Zhang, Bin Mi, John D. Hatlestad
  • Patent number: 8019438
    Abstract: The present invention is device for delivering an electrode into a lateral vein of the coronary sinus. The device includes a support structure, a stent, a tether coupled to the stent and a removable sheath disposed about the stent. The stent is carried on the support structure and is deployable from a first collapsed configuration to a second expanded configuration for engaging the inner walls of the selected vessel. The sheath is sized to retain the stent in the first collapsed configuration. The electrode is carried on the stent or on a lead threaded over the tether.
    Type: Grant
    Filed: June 28, 2005
    Date of Patent: September 13, 2011
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Eric T. Johnson, Bruce A. Tockman
  • Patent number: 7207939
    Abstract: An apparatus and method for determining the density and fluid-type of a fluid flowing in a capillary tube, the velocity and viscosity of a blood sample flowing in a capillary tube, the erythrocyte sedimentation rate (ESR) of a blood sample after flow has been brought to an abrupt stop in a capillary tube, and/or the zeta sedimentation rate (ZSR) of a blood sample after flow has been brought to an abrupt stop in a capillary tube. These measurements are accomplished by directing a waveform pulse, such as an ultrasound pulse, at a pre-determined frequency transversely across the capillary tube and sample fluid, and by determining the flight of time of the pulse through the capillary tube and sample fluid and/or the Doppler shift of the echo signals reflecting off cells moving forwardly or transversely within a flowing, or stationary, blood sample.
    Type: Grant
    Filed: October 3, 2002
    Date of Patent: April 24, 2007
    Assignee: Coulter International Corp.
    Inventor: Frederick K. Husher
  • Patent number: 6632679
    Abstract: Method and apparatus to determine the speed of sedimentation of blood and other parameters connected thereto, said method being carried out by detecting the development over time of the optical density, or absorbance, of a sample of blood, said sample being sent in the form of a flow inside a capillary container (12), said detection being made in correspondence with a point of said capillary container (12) and the relative data acquired being processed to obtain said speed of sedimentation and said connected parameters, said method providing to instantly interrupt the flow of the blood sample flowing inside said capillary container (12), in order to determine a thickening of the red cells in said blood sample and their consequent sedimentation, said detection being made substantially simultaneously with said instant interruption.
    Type: Grant
    Filed: February 9, 2000
    Date of Patent: October 14, 2003
    Assignee: Sire Analytical Systems Srl
    Inventor: Enzo Breda
  • Publication number: 20030069488
    Abstract: A constriction device that constricts body tissue includes fixation structures for fixing the device on constricted body tissue. The device includes an elongated sleeve including an inner surface and opposed opened ends. The device is formed from expandable or elastic material so that when in an expanded condition, body tissue to be constricted may be received therein and thereafter, when released from the expanded condition, the body tissue is constricted by the device. The fixation structures include a plurality of fixation elements on the inner surface of the sleeve that grasp the body tissue upon release of the sleeve from the expanded condition to fix the device on the constricted tissue.
    Type: Application
    Filed: November 4, 2002
    Publication date: April 10, 2003
    Applicant: Spiration, Inc.
    Inventors: Clifton A. Alferness, Robert Barry, Clint Finger, Leslie Snyder, Jenni Rimbaugh
  • Patent number: 6531321
    Abstract: A control and system for blood testing, including a control having stabilized blood cells that have been introduced into a suspension including an aggregating agent and preferably a surfactant. The control and system is used advantageously for indirect acute protein plasma measurement, including erythrocyte sedimentation rate testing.
    Type: Grant
    Filed: September 15, 2000
    Date of Patent: March 11, 2003
    Assignee: Streck Laboratories, Inc.
    Inventors: Wayne L. Ryan, Bradford A. Hunsley
  • Publication number: 20020169370
    Abstract: A blood viscosity measuring system and method that monitors the rising head of a column of fluid representing a living being's blood in-vivo to determine the blood viscosity over a range of shears. The system includes a capillary tube, at least a portion of which is located within the vascular system of the being, and a riser tube, having a liquid therein coupled to the capillary tube. A sensor and associated microprocessor are provided to determine the change in the height of the liquid in the riser tube at plural points along the length of the tube from which the viscosity is calculated.
    Type: Application
    Filed: June 28, 2002
    Publication date: November 14, 2002
    Applicant: RHEOLOGICS, INC.
    Inventors: Kenneth Kensey, John E. Nash, Harold E. Clupper
  • Publication number: 20020143244
    Abstract: A method and apparatus for testing the efficacy of agents (e.g., new drugs, old drugs, biologically-active agents, etc.) by removing a predetermined amount of blood from a living being and placing this predetermined amount of blood in continuous motion in a temperature-controlled environment and then removing samples from the continuously-moving predetermined amount of blood. The drug, or drugs, or agents under test can then be administered to the removed samples, instead of into the living being, thereby avoiding subjecting the living being to any risk of any adverse reaction while utilizing blood samples that simulate the circulating blood of the living being.
    Type: Application
    Filed: February 5, 2002
    Publication date: October 3, 2002
    Applicant: Rheologics, Inc.
    Inventors: Kenneth Kensey, William N. Hogenauer
  • Patent number: 6331435
    Abstract: A three-phase suspension suitable for use as an erythrocyte sedimentation rate control having the following three components: (1) a synthetic plasma base, (2) a high molecular weight polymer, and (3) mammalian red blood cells. The control is designed to allow the user to monitor the accuracy and precision of analytical methods for determining the sedimentation rate of human erythrocytes in whole blood specimens.
    Type: Grant
    Filed: October 12, 1999
    Date of Patent: December 18, 2001
    Assignees: Streak Laboratories, Inc., Hematronix Inc.
    Inventor: Wayne R. Hengstenberg
  • Patent number: 6146327
    Abstract: In a method for measuring in vivo coagulation rate, a fold of organic tissues is clamped so that a target blood vessel contained in the organic tissues is closed at a downstream point and an upstream point spaced from one another. Waveform energy is then directed through the clamped organic tissues. Waveform energy transmitted at least partially through the organic tissues is analyzed to determine a state of coagulation of blood trapped in the blood vessel between the downstream point and upstream point.
    Type: Grant
    Filed: August 4, 1998
    Date of Patent: November 14, 2000
    Inventor: Peter J. Wilk
  • Patent number: 6135957
    Abstract: This invention includes a method of determining the viscosity and the pressure gradient in a blood vessel, including the acquisition of n.gtoreq.2 blood speed values, corresponding to the same number of n radii of the blood vessel, determined along a diameter situated in a given axial position, formation of a blood speed vector by means of said n blood speed values, and evaluation of said viscosity and pressure gradient on the basis of a transformation of said blood speed value, including formation of a linear relation which directly links a flow rate vector (y) to the speed derivative vector (h), factorized by the viscosity (.mu.), and to the pressure gradient vector (.sigma.), and simultaneous evaluation of the two values to be determined for the viscosity (.mu.) and the pressure gradient (.sigma.) on the basis of said direct equation. The velocities are advantageously determined by correlation of ultrasonic signals supplied by an echography apparatus.
    Type: Grant
    Filed: January 22, 1999
    Date of Patent: October 24, 2000
    Assignee: U.S. Philips Corporation
    Inventors: Claude Cohen-Bacrie, Fabrice Bruni, Odile Bonnefous
  • Patent number: 5916814
    Abstract: A presealed integral hematocrit test assembly includes a holder, a bore molded into the holder, and a blood sample tube mounted on the holder adapted to receive a sample of blood by capillary action, whereby the blood sample tube is filled with blood from its inlet end by capillary action, and the test assembly is centrifuged into a column having a red corpuscles portion, white corpuscles portion, and a plasma portion. The method of using the presealed integral hematocrit test assembly includes the steps of measuring the length of the red cells column portion and measuring the total length of the blood column, and dividing the length of the red cells column portion by the total length of the blood column to make the hematocrit determination.
    Type: Grant
    Filed: October 9, 1996
    Date of Patent: June 29, 1999
    Assignee: Drummond Scientific Company
    Inventor: James W. Kenney
  • Patent number: 5863799
    Abstract: A three-phase solution suitable for use as an erythrocyte sedimentation rate control having the following three components: (1) a synthetic plasma base, (2) a high molecular weight polymer, and (3) mammalian red blood cells. The control is designed to allow the user to monitor the accuracy and precision of analytical methods for determining the sedimentation rate of human erythrocytes in whole blood specimens.
    Type: Grant
    Filed: September 5, 1997
    Date of Patent: January 26, 1999
    Assignee: Hycor Biomedical, Inc.
    Inventor: Wayne R. Hengstenberg